Papers
7
Total Citations
242
H-Index
4
About
Dr. David F. Friedlander is a leading urologic oncologist and health services researcher whose work focuses on the comparative effectiveness, cost, and patient-centered outcomes of robotic cancer surgery. His major contributions include landmark studies evaluating robot-assisted versus open radical cystectomy, which have garnered over 75 citations and helped shape surgical decision-making for bladder cancer. Dr. Friedlander has also advanced the field through his detailed descriptions of bladder neck sparing techniques during robotic prostatectomy, demonstrating improved continence without compromising cancer control—a finding cited over 50 times. His research extends beyond the operating room, critically examining the financial burden of robotic surgery on patients, as seen in his highly cited work on out-of-pocket costs. Notably, he has investigated the impact of the COVID-19 pandemic on urologic oncology surgeries and workplace absenteeism following robotic versus open procedures. With a publication record spanning over 240 citations, Dr. Friedlander’s work is essential reading for clinicians and researchers seeking evidence-based insights into the real-world implications of robotic surgical technologies.
Research Focus
Key Achievements
Top Papers
- 1Comparative effectiveness of robot-assisted vs. open radical cystectomy75 citations · 2017
- 2The current status of robotic oncologic surgery71 citations · 2012
- 3
- 4Assessment of Out-of-Pocket Costs for Robotic Cancer Surgery in US Adults36 citations · 2020
- 5
- 6Impact of COVID-19 pandemic on ambulatory urologic oncology surgeries.2 citations · 2023
- 7